HIF-alpha inhibitors (Piramal Life Sciences)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameHIF-alpha inhibitors (Piramal Life Sciences)
Drug Alias NameHIF-alpha modulators (Nicholas Piramal)HIF-alpha modulators (Piramal Life Sciences)Pxxx (Nicholas Piramal)P-2630
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHypoxia-inducible factor 1 alpha inhibitorsHypoxia-inducible factor 1 alpha modulators
TargetsHypoxia-inducible factor 1 alpha
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPiramal Enterprises Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A